Clonality and Measurable Residual Disease (MRD) Testing on the Illumina NextSeq Sequencers ← ALL PUBLICATIONS Clonality and Measurable Residual Disease (MRD) Testing on the Illumina® NextSeqTM Sequencers June 2024 AUTHOR Austin Jacobsen 2025-09-18T16:20:55-07:00